193 related articles for article (PubMed ID: 28924346)
1. Co-delivery of polyinosinic:polycytidylic acid and flagellin by poly(lactic-
Dai X; He J; Zhang R; Wu G; Xiong F; Zhao B
Int J Nanomedicine; 2017; 12():6617-6632. PubMed ID: 28924346
[TBL] [Abstract][Full Text] [Related]
2. Surface-functionalized, pH-responsive poly(lactic-co-glycolic acid)-based microparticles for intranasal vaccine delivery: Effect of surface modification with chitosan and mannan.
Li Z; Xiong F; He J; Dai X; Wang G
Eur J Pharm Biopharm; 2016 Dec; 109():24-34. PubMed ID: 27569030
[TBL] [Abstract][Full Text] [Related]
3. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally.
Jaganathan KS; Vyas SP
Vaccine; 2006 May; 24(19):4201-11. PubMed ID: 16446012
[TBL] [Abstract][Full Text] [Related]
4. Aerosolized PLA and PLGA nanoparticles enhance humoral, mucosal and cytokine responses to hepatitis B vaccine.
Thomas C; Rawat A; Hope-Weeks L; Ahsan F
Mol Pharm; 2011 Apr; 8(2):405-15. PubMed ID: 21189035
[TBL] [Abstract][Full Text] [Related]
5. Stabilization and immune response of HBsAg encapsulated within poly(lactic-co-glycolic acid) microspheres using HSA as a stabilizer.
Xu W; He J; Wu G; Xiong F; Du H; Wang G
Int J Pharm; 2015 Dec; 496(2):332-41. PubMed ID: 26453785
[TBL] [Abstract][Full Text] [Related]
6. Development of a single-dose stabilized poly(D,L-lactic-co-glycolic acid) microspheres-based vaccine against hepatitis B.
Jaganathan KS; Singh P; Prabakaran D; Mishra V; Vyas SP
J Pharm Pharmacol; 2004 Oct; 56(10):1243-50. PubMed ID: 15482638
[TBL] [Abstract][Full Text] [Related]
7. [Immunogenicity of single-dose HBsAg-PLGA controlled release microspheres in mice].
Feng L; Zhou XJ; Wang SC; Jiang Y; Qi XR
Yao Xue Xue Bao; 2006 Feb; 41(2):132-7. PubMed ID: 16671543
[TBL] [Abstract][Full Text] [Related]
8. Influence of surface charge of PLGA particles of recombinant hepatitis B surface antigen in enhancing systemic and mucosal immune responses.
Thomas C; Gupta V; Ahsan F
Int J Pharm; 2009 Sep; 379(1):41-50. PubMed ID: 19524654
[TBL] [Abstract][Full Text] [Related]
9. Particle size influences the immune response produced by hepatitis B vaccine formulated in inhalable particles.
Thomas C; Gupta V; Ahsan F
Pharm Res; 2010 May; 27(5):905-19. PubMed ID: 20232117
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of immune response of HBsAg loaded poly (L-lactic acid) microspheres against hepatitis B through incorporation of alum and chitosan.
Pandit S; Cevher E; Zariwala MG; Somavarapu S; Alpar HO
J Microencapsul; 2007 Sep; 24(6):539-52. PubMed ID: 17654174
[TBL] [Abstract][Full Text] [Related]
11. Poly(I:C) coated PLGA microparticles induce dendritic cell maturation.
Wischke C; Zimmermann J; Wessinger B; Schendler A; Borchert HH; Peters JH; Nesselhut T; Lorenzen DR
Int J Pharm; 2009 Jan; 365(1-2):61-8. PubMed ID: 18812217
[TBL] [Abstract][Full Text] [Related]
12. Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity.
Pawar D; Mangal S; Goswami R; Jaganathan KS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):550-9. PubMed ID: 23831265
[TBL] [Abstract][Full Text] [Related]
13. Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres.
Shi L; Caulfield MJ; Chern RT; Wilson RA; Sanyal G; Volkin DB
J Pharm Sci; 2002 Apr; 91(4):1019-35. PubMed ID: 11948541
[TBL] [Abstract][Full Text] [Related]
14. Enhanced stimulation of anti-breast cancer T cells responses by dendritic cells loaded with poly lactic-co-glycolic acid (PLGA) nanoparticle encapsulated tumor antigens.
Iranpour S; Nejati V; Delirezh N; Biparva P; Shirian S
J Exp Clin Cancer Res; 2016 Oct; 35(1):168. PubMed ID: 27782834
[TBL] [Abstract][Full Text] [Related]
15. Comparison of humoral and cell-mediated immune responses to cationic PLGA microspheres containing recombinant hepatitis B antigen.
Saini V; Jain V; Sudheesh MS; Jaganathan KS; Murthy PK; Kohli DV
Int J Pharm; 2011 Apr; 408(1-2):50-7. PubMed ID: 21291968
[TBL] [Abstract][Full Text] [Related]
16. Microspheres prepared with different co-polymers of poly(lactic-glycolic acid) (PLGA) or with chitosan cause distinct effects on macrophages.
Bitencourt Cda S; Silva LB; Pereira PA; Gelfuso GM; Faccioli LH
Colloids Surf B Biointerfaces; 2015 Dec; 136():678-86. PubMed ID: 26497115
[TBL] [Abstract][Full Text] [Related]
17. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis.
Ohashi K; Kabasawa T; Ozeki T; Okada H
J Control Release; 2009 Apr; 135(1):19-24. PubMed ID: 19121349
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of mucoadhesive PLGA microparticles for nasal immunization.
Pawar D; Goyal AK; Mangal S; Mishra N; Vaidya B; Tiwari S; Jain AK; Vyas SP
AAPS J; 2010 Jun; 12(2):130-7. PubMed ID: 20077052
[TBL] [Abstract][Full Text] [Related]
19. [Preparation, release and immunogenicity evaluation of HBsAg-PLGA microspheres].
Feng L; Zhou XJ; Qi XR
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 37(5):527-31. PubMed ID: 16224529
[TBL] [Abstract][Full Text] [Related]
20. Protective immunity in rats by intranasal immunization with Streptococcus mutans glucan-binding protein D encapsulated into chitosan-coated poly(lactic-co-glycolic acid) microspheres.
Zhao H; Wu B; Wu H; Su L; Pang J; Yang T; Liu Y
Biotechnol Lett; 2006 Aug; 28(16):1299-304. PubMed ID: 16804764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]